Clinical Trial

Effect of HIgh-flow Therapy in Long-term Oxygen Therapy

Study acronym: HILOT
Recruiting
View on ClinicalTrials.gov →
Summary
This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-06; most recent amendment 2025-05-15.
Status change: Not Yet Recruiting → Recruiting 2024-06-10
Trial Details
NCT Number NCT06247397
Lead Sponsor Skane University Hospital
Collaborators: Uppsala University Hospital, Region Stockholm, Region Örebro County, Blekinge County Council Hospital, Blekinge Institute of Technology, Lund University, Region Östergötland, Vastra Gotaland Region, Region Västerbotten, Landstinget i Värmland, ResMed, Swedish Heart Lung Foundation, The Swedish Research Council
Conditions Chronic Obstructive Pulmonary Disease Severe, Interstitial Lung Disease, Chronic Respiratory Failure With Hypoxia
Enrollment 310 participants
Start Date 2024-06-10
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-21